01 Apr Date April 1, 2024 Author TelaraPharma Telara Pharma awarded €841.000 from Spanish government to characterize the mechanism of action of cilastatin to act as a preventive treatment in acute and chronic inflammatory indications Telara Pharma (Lead coordinator, Madrid, Spain), Fundación para la Investigación Biomédica del Hospital Gregorio Marañón (FIB...
05 Apr Date April 5, 2023 Author TelaraPharma Telara Pharma has been awarded a €325,000 non-refundable grant through the Spanish Ministry of Science and Innovation Neotec programme, managed by the Centre for the Development of Industrial Technology (CDTI). Neotec is a highly competitive programme that aims to foster technology and innovation for the development of companies based in S...